智通财经APP获悉,思派健康(00314)午后涨超10%,截至发稿,涨9.03%,报6.76港元,成交额9775.01万港元。
消息面上,7月1日,国家医保局公布《支持创新药高质量发展的若干措施》文件,其中,商业健康保险创新药品目录备受业界关注。7月24日,国家医疗保障局局长章轲在国新办新闻发布会上表示,最近大家比较关注“医保双目录”改革,新设立了商业健康保险创新药目录,这是医保支持医药创新的扎实举措之一。目前一共有超过100个药品申报了创新药目录,接下来国家医保局会按程序做好后续工作。
据悉,4月24日,复星联合健康保险与思派健康在上海正式签署战略合作协议。6月26日,思派健康与国际保险服务集团安睿嘉尔签订战略合作协议。作为国内少数同时具备医疗服务管理能力和健康保险业务资质的科技平台,思派健康旗下思派大药房拥有全国性药品流通牌照,而其联合保险公司推出的特药险、带病体保险等创新产品,填补了传统健康险的市场空白。此外,随着商业医疗保险渗透率提升和创新药市场扩容,公司独特的生态闭环价值有望获得更充分定价。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.